Recall Notification From Alliance Healthcare - Glenmark Pharmaceuticals Europe Limited

Published: Fri, 01/23/26

Recall Notification From Alliance Healthcare - Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited

23 January 2026

Dear Member,

Please see recall information attached in the Alliance Healthcare email notification about:

Update from GOV.UK for: Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules, EL(26)A/02

If you have any questions or inquiries please get in touch with us as usual on

info@pharmaplusltd.co.uk

Regards,

PharmaPlus

Pharma Plus Ltd.

Unit B1-B3, Livingstone Court, 55 Peel Road, Harrow, Middlesex HA37QT

info@pharmaplusltd.co.uk | Tel: 020 8863 3335 | Fax: 020 8863 4144 | www.pharmaplusltd.co.uk

Missed an email? Click here for an archive of our most recent communications!

NOTICE

The information contained in this electronic transmission is protected by privilege (which is not waived), strictly confidential and intended for use only by the addressee. If you receive this electronic transmission by mistake then the dissemination distribution or copying of it is strictly prohibited. In such a case please contact us immediately by telephone or return this electronic transmission.

PharmaPlus
Unit B1, Livingstone Court, 55 Peel Road
Harrow Middlesex HA3 7QT
UNITED KINGDOM

Unsubscribe | Change Subscriber Options